The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

A Cambridge biotech company is preparing to lay off its entire staff of more than 300 after being acquired by another firm.